| ASSET | YEAR | % RETURN |
|---|---|---|
Lexicon Pharmaceuticals (LXRX) | 2010 | -17.24% |
Lexicon Pharmaceuticals (LXRX) | 2011 | -11.03% |
Lexicon Pharmaceuticals (LXRX) | 2012 | 67.42% |
Lexicon Pharmaceuticals (LXRX) | 2013 | -21.44% |
Lexicon Pharmaceuticals (LXRX) | 2014 | -48.88% |
Lexicon Pharmaceuticals (LXRX) | 2015 | 104.45% |
Lexicon Pharmaceuticals (LXRX) | 2016 | 5.81% |
Lexicon Pharmaceuticals (LXRX) | 2017 | -30.62% |
Lexicon Pharmaceuticals (LXRX) | 2018 | -33.47% |
Lexicon Pharmaceuticals (LXRX) | 2019 | -36.35% |
Lexicon Pharmaceuticals (LXRX) | 2020 | -17.59% |
Lexicon Pharmaceuticals (LXRX) | 2021 | 13.54% |
Lexicon Pharmaceuticals (LXRX) | 2022 | -51.4% |
Lexicon Pharmaceuticals (LXRX) | 2023 | -21.13% |
Lexicon Pharmaceuticals (LXRX) | 2024 | -50.44% |
Lexicon Pharmaceuticals (LXRX) | 2025 | 80.26% |
